Literature DB >> 15464030

Autonomic receptor systems in the failing and aging human heart: similarities and differences.

Otto-Erich Brodde1, Kirsten Leineweber.   

Abstract

Changes in autonomic receptor systems (alpha- and beta-adrenoceptors and muscarinic receptors) were compared in the aging and failing human heart. In both settings responsiveness of beta-adrenoceptors and all other receptor systems that evoke their effects via cyclic AMP accumulation was diminished. Muscarinic receptor function, on the other hand, was decreased in the aging, but unchanged in the failing heart; in contrast, G protein-coupled receptor kinase activity was increased in the failing, but unchanged in the aging heart. alpha-Adrenoceptor function was unchanged or slightly decreased in the failing heart. However, nothing is known on alpha-adrenoceptor changes in the aging heart. These results indicate that in the failing human heart all autonomic receptor systems appear to be altered in the direction to attenuate beta-adrenoceptor responses to sympathetic (over)stimulation while in the aging human heart autonomic receptor systems appear to be altered in a direction that protects the heart against too pronounced reduction in beta-adrenoceptor responsiveness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464030     DOI: 10.1016/j.ejphar.2004.07.022

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

Review 2.  Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.

Authors:  Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-11       Impact factor: 3.000

3.  Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter.

Authors:  Brett A English; Martin Appalsamy; Andre Diedrich; Alicia M Ruggiero; David Lund; Jane Wright; Nancy R Keller; Katherine M Louderback; David Robertson; Randy D Blakely
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-02       Impact factor: 4.733

4.  The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.

Authors:  Kirsten Leineweber; Ulrich H Frey; Gero Tenderich; Mohammad Reza Toliat; Armin Zittermann; Peter Nürnberg; Reiner Körfer; Winfried Siffert; Gerd Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-29       Impact factor: 3.000

5.  Influence of age on inducibility and cholinergic modulation of arrhythmia in isolated rat right atria.

Authors:  D M Faria; A G Viviane; K M Galvão; A Caricati-Neto; C M G Godoy
Journal:  Age (Dordr)       Date:  2008-11-19

Review 6.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Sex and age effects on cardiovascular autonomic function in healthy adults.

Authors:  Jean-Pierre Ndayisaba; Alessandra Fanciulli; Roberta Granata; Susanne Duerr; Florian Hintringer; Georg Goebel; Florian Krismer; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2015-08-20       Impact factor: 4.435

Review 8.  Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.

Authors:  Kirsten Leineweber; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

9.  (-)-Epigallocatechin-3-gallate, the major green tea catechin, regulates the desensitization of β1 adrenoceptor via GRK2 in experimental heart failure.

Authors:  Qi Zhang; Liqun Hu; Li Chen; Hongqi Li; Jun Wu; Wenting Liu; Mengyuan Zhang; Guang Yan
Journal:  Inflammopharmacology       Date:  2017-12-16       Impact factor: 4.473

Review 10.  The current status of beta blockers' use in the management of hypertension.

Authors:  Shahid Akbar; Mohammad S Alorainy
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.